Azzad Asset Management Inc /Adv Neurocrine Biosciences Inc Transaction History
Azzad Asset Management Inc /Adv
- $1.01 Trillion
- Q3 2025
A detailed history of Azzad Asset Management Inc /Adv transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 8,946 shares of NBIX stock, worth $1.38 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
8,946Holding current value
$1.38 Million% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
695Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$1.5 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$862 Million0.42% of portfolio
-
Jpmorgan Chase & CO New York, NY4.73MShares$732 Million0.04% of portfolio
-
State Street Corp Boston, MA4.47MShares$692 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...